Intravenous gold-induced autologous serum injection therapy (Go ACT®) as a new treatment for seasonal pollen-based allergies

Volume: 25, Issue: 11, Pages: 4121 - 4127
Published: Jun 1, 2021
Abstract
Objective null This prospective case study investigated the new therapeutic paradigm of autologous gold-induced immunotherapy (Go ACT®) in the treatment of pollen-based allergies. The safety and clinical efficacy of Go ACT® were investigated by assessing patients in the first pollen season following treatment with Go ACT®. null Patients and methods null In this prospective case study, patients were enrolled who had a proven pollen allergy and...
Paper Details
Title
Intravenous gold-induced autologous serum injection therapy (Go ACT®) as a new treatment for seasonal pollen-based allergies
Published Date
Jun 1, 2021
Volume
25
Issue
11
Pages
4121 - 4127
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.